TGTing Guo

Ting Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ting Guo has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Gu

    Department of Gynaecology, Obstetrics and Gynaecology Hospital, Fudan University, Shanghai, 200011, People's Republic of China

    4 shared publications
  • Bin Li

    Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases Shanghai China

    3 shared publications
  • Chenchen Feng

    Department of Urology, Huashan Hospital, Fudan University

    3 shared publications
  • Congjian Xu

    Department of Gynaecology, Obstetrics and Gynaecology Hospital, Fudan University, Shanghai, 200011, People's Republic of China

    2 shared publications
  • Xiuying Chen

    Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases Shanghai China

    2 shared publications
  • Bin Li

    1 shared publication

Latest Publications

  • Open Access

    A comprehensive study of intratumor bacteria in clear-cell renal cell carcinoma identifies Cutibacterium acnes as a protector via suppression of macrophage M2 polarization

    by Yuqing Li, Dengwei Zhang, Linyi Tan, Junyao Xu, Yang Sun, Rui Zhang, Yao Cheng, Yong-Xin Li, Ting Guo, Haowen Jiang, et al.

    Intratumor bacteria (ITB) have emerged as key modulators in various malignancies; however, their role in clear-cell renal cell carcinoma (ccRCC) remains unclear and elusive. In this study, we analyzed seven independent cohorts (comprising one 16S rRNA sequencing and six bulk RNA sequencing data sets) encompassing 517 ccRCC and 65 paired adjacent normal tissues. Following a rigorous decontamination pipeline, we found that neither microbial diversity nor compositional profiles differed significantly between cancerous and adjacent normal tissues. Thirteen specific genera—including Streptococcus , Rothia , Cutibacterium , and Corynebacterium —exhibited significant prognostic associations. The microbial risk scores constructed from these genera demonstrated robust performance in prognostic risk stratification and were validated as an independent prognostic factor for both overall survival and progression-free survival, respectively. Host-microbe interaction analysis revealed correlations between these prognostic genera and oncogenic pathways, particularly those involved in immune regulation and metabolism. Notably, culturomics successfully isolated Cutibacterium acnes ( C. acnes ) from ccRCC tissues, and higher C. acnes' abundance was correlated with a favorable prognosis. Functional assays revealed that C. acnes inhibits tumor growth and suppresses macrophage M2 polarization. Mechanistically, C. acnes and its primary metabolite, propionic acid, attenuate macrophage M2 polarization by activating TNF signaling. Our findings underscore the protective role of C. acnes in the ccRCC microenvironment and highlight its potential as a target for precision immunotherapy. IMPORTANCE: To address previous methodological limitations, we applied rigorous decontamination to multi-omic datasets to isolate and experimentally validate intratumor bacteria colonization in ccRCC. Comparable profiles between tumorous and normal tissues suggest intratumor bacteria generally act as “passengers.” We successfully constructed robust microbial risk scores predictive of patient survival. Mechanistically, in vitro and in vivo models demonstrated that Cutibacterium acnes and its metabolite, propionic acid, inhibit tumor growth and suppress M2 macrophage polarization via TNF signaling. These findings highlight the protective role of Cutibacterium acnes in the tumor microenvironment, revealing it as a promising target for precision immunotherapy.

  • Loss of TIPARP ‐Mediated RNA Regulatory Mechanisms Activates TGF ‐β Signaling to Drive Fibroblast‐Dependent Chemoresistance in Ovarian Cancer

    by Wenqi Fan, Chenchen Feng, Xiuying Chen, Haiyan Wang, Bin Li, Shien Zou, Ting Guo

    Background: Chemoresistance in ovarian cancer involves dynamic tumor microenvironment (TME) remodeling, yet the role of RNA regulatory mechanisms in stromal reprogramming remains unclear. Methods: We integrated single‐cell RNA‐seq (GSE165897), spatial transcriptomics (GSE21956), and multi‐omics analyses from 11 ovarian cancer patients (resistant [Res] vs. sensitive [Sen] groups). FUSION pipeline identified RNA modification‐associated loci through regulome‐wide association studies (RWAS), while MAGMA linked GWAS variants to cell types. Functional assays included pseudotime trajectory (Monocle) and cell communication (CellChat). Results: We identified 23 significant genes, including TIPARP, associated with RWAS loci. Fibroblasts in Res patients exhibited reduced TIPARP expression during differentiation, paralleling TGF‐β pathway activation. Spatial mapping revealed TGFB1+ endothelial cells co‐localized with TIPARP+ fibroblasts (Pearson's r = 0.71, p < 0.001). Mechanistically, TIPARP R‐loops overlapped TWAS regions (chr3:156672025–156711450), suggesting epigenetic regulation. Res‐fibroblasts showed activated TGF‐β signaling. Conclusion: Reduced expression of TIPARP is associated with fibroblast chemoresistance via TGF‐β activation, highlighting a targetable RNA regulatory mechanism–stromal crosstalk axis.

  • Inhibition of succinate dehydrogenase sensitizes cyclin E‐driven ovarian cancer to CDK inhibition

    by Ting Guo, Chao Gu, Xiuying Chen, Yu Kang, Bin Li, Congjian Xu

    Aim: High‐grade serous ovarian cancer (HGS‐OvCa) is characterized by widespread CCNE1 amplification. Current treatments lack specificity to target Cyclin E‐driven OvCa. Methods: By in silico analysis of the TCGA OvCa dataset we searched association between genes involved in glucose metabolism and cell cycle control. Metabolic shift was studied in Cyclin E‐driven OvCa cells treated with CDK inhibition (CDKi). Genetic and pharmaceutical inhibition of succinate dehydrogenase (SDH) was tested in combination with CDKi. Results: OvCa patients with CCNE1 amplification could be divided by concomitant SDHA amplification. A2780 OvCa cells were similar to the Cyclin E‐driven and SDHA neutral genotype. CDKi in A2780 cells using Dinaciclib resulted in compensatory enhancement of tricarboxylicacid cycle (TCA) cycle activity. Combined blockade of CDK and SDH, both genetically and pharmaceutically, showed synergy and resulted in inhibited proliferation, migration, invasion and migration in A2780 cells. The combined inhibition did not further alter cell cycle population, but induced apoptosis of A2780 cells. Conclusion: Cyclin E‐driven OvCa cells appeared addicted to glucose metabolism via TCA. Combined CDKi with modalities targeting TCA, like SDHA inhibition showed promising effects for this genotype. © 2016 BioFactors, 42(2):171–178, 2016


  • Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer

    by Ting Guo, Tao Chen, Chao Gu, Bin Li, Congjian Xu

    We aimed to evaluate the role of glucose-6-phosphatase, catalytic subunit (G6PC) in ovarian cancer and to exploit its therapeutic potential. With reproduction of The Cancer Genome Atlas (TCGA) database, we studied expressions of genes in the glucose metabolism pathways in silico. The cBioPortal For Cancer Genomics was used to study the clinical, pathological and molecular profiles of G6PC. In vitro studies were performed to validate the function of G6PC and the effect of genetic and pharmaceutical G6PC inhibition. In 158 ovarian cancer (OvCa) patients with complete RNA-seq data, G6PC expression was increased in 27 patients (17 %). Both overall survival (OS) and disease-free period were significantly shorter in cases with increased G6PC level. Significantly decreased total and phosphorylated CDKN1B level was noted in OvCa with increased G6PC expression. Silenced G6PC in OvCa cells induced decreased cell proliferation, viability, invasiveness and anchorage-independent cell growth. G6PC silencing also induced enhanced cell cycle control proteins and restoration of CDKN1B level. Pharmaceutical inhibition of G6PC with specific compound showed similar effects to genetic silencing. G6PC played dual roles both in glucose metabolism and cell cycle control in OvCa, which potentiated it a promising therapeutic target.


    • 15 December 2013
      • Vol. 7  (1) , 144-51

    A mouse model of premature ovarian insufficiency induced by tripterygium glycoside via subcutaneous injection.

    by Xiu-Ying Chen, Chao Gu, Min Ma, Qing Cong, Ting Guo, Duan Ma, Bin Li

    Premature ovarian insufficiency (POI) is a main cause of infertility and affects nearly 1% women under 40 years old. This study was aimed to utilize the side effects of tripterygium glycoside (TG) to induce a mouse model of POI. 48 female KM mice were divided into four groups: control, oral, intraperitoneal injection and subcutaneous injection group. The mice in last three groups were treated with TG (50 mg•kg(-1)) daily for 35 days, while the mice in control group were treated with parallel volume of sterile water. Vaginal smears were taken to monitor the estrous cycles and estrous frequency for the last 21 days. Ovarian and uterine index and histomorphological change were determined when finished the administration. Serum levels of FSH were assessed by ELISA. Ki-67 expression in the uterus was analyzed from using immunohistochemical detection. And the apoptosis of follicle cells were detected by TUNEL assay. The results showed that mice in subcutaneous injection group presented the critical manifestations with significantly prolonged estrous cycles, decreased estrous frequency, reduced ovarian and uterine index, and increased serum FSH levels. At this dose level, TG could reduce developing follicles and corpus luteum, and increase atretic follicles, which might be induced by the increasing levels of follicle apoptosis. The proliferation index of uterus, evaluated by histomorphological changes and the expression of Ki-67, was significantly suppressed in TG treated animals. These data suggested that TG was feasible to induce a mice model via subcutaneous injection which could mimic the manifestations of POI.


    • 3 July 2013
      • Vol. 18  (2) , 465-70

    Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma.

    by Ting Guo, Bin Li, Chao Gu

    To investigate the expression of human phosphatidylethanolamine- binding protein 4 (hPEBP4) in endometrial carcinoma and its relation with progesterone receptor (PR) and estrogen receptor (ER). Forty-five samples of endometrioid endometrial carcinoma (EEC), 12 samples of atypical endometrial hyperplasia, and 30 samples of normal endometrium were examined. Samples were studied by immunohistochemistry for PR, ER and hPEBP4 expression. Expressions were statistically quantified and analyzed. Expressions of PR and ER were significantly higher in normal endometrium than in cancer. Expression of hPEBP4 was significantly lower in normal endometrium. The expression of hPEBP4 was significantly higher in advanced-stage endometrial cancer, whilst higher but insignificant trend was noticed in higher grade carcinoma. Statistically insignificant trend of negative ER and PR expression with higher grade or stage was noticed. The expression of hPEBP4 was negatively correlated to ER and PR in EEC. The expression pattern of hPEBP4 indicated that hPEBP4 interacted with ER and PR in EEC and could thus become a possible target for the development of novel treatment against this malignancy.


  • Open Access

    Endoureterotomy is not a sufficient treatment for intrinsic ureteral endometriosis

    by Ting Guo, Chao Gu, Chenchen Feng, Qiang Ding, Congjian Xu, Bin Li

    Aim : To investigate whether intrinsic ureteral endometriosis could be managed by laser endoureterotomy. Material and methods : We studied retrospectively 6 patients with intrinsic ureteral endometriosis who underwent laser endoureterotomy and reviewed their clinical data. Pathological...